Anemia in myelofibrosis significantly affects survival and quality of life, with severe anemia reducing median survival ...

The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...

STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the ...

Patients with myelofibrosis and anemia showed similar spleen size and symptom improvements as the overall JUMP study cohort when treated with ESAs or danazol and Jakafi. The JUMP trial, a phase 3b ...

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

The Aplastic Anemia market presents opportunities in novel therapies, with 5+ companies and 8+ drugs in various development stages. Key focus is on innovative treatment approaches, partnerships, and ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Constantly feeling cold can be an indicator of various health problems, environmental factors, or a certain lifestyle. If you ...

A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

Disc Medicine, Inc. (($IRON)) announced an update on their ongoing clinical study. Disc Medicine, Inc. is conducting a study titled RALLY-MF: A ...